Literature DB >> 20153754

A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).

Salvatore Genovese1, Jennifer E Foreman, Michael G Borland, Francesco Epifano, Frank J Gonzalez, Massimo Curini, Jeffrey M Peters.   

Abstract

AIMS: Previous studies showed that natural prenyloxyphenylpropanoid derivatives have potent biological properties in vivo. Given the structural similarities between these compounds and known peroxisome proliferator-activated receptor (PPAR) agonists, the present study examined the hypothesis that propenoic acid derivatives activate PPARs. MAIN
METHODS: Chimeric reporter assays were performed to identify propenoic acid derivates that could activate PPARs. Quantitative polymerase chain reaction (qPCR) analysis of wild-type and Pparbeta/delta-null mouse primary keratinocytes was performed to determine if a test compound could specifically activate PPARbeta/delta. A human epithelial carcinoma cell line and primary mouse keratinocytes were used to determine the effect of the compound on cell proliferation. KEY
FINDINGS: Three of the propenoic acid derivatives activated PPARs, with the greatest efficacy being observed with prenyloxycinnamic acid derivatives 4'-geranyloxyferulic acid (compound 1) for PPARbeta/delta. Compound 1 increased expression of a known PPARbeta/delta target gene through a mechanism that requires PPARbeta/delta. Inhibition of cell proliferation by compound 1 was found in a human epithelial carcinoma cell line. SIGNIFICANCE: Results from these studies demonstrate that compound 1 can activate PPARbeta/delta and inhibit cell proliferation of a human skin cancer cell line, suggesting that the biological effects of 4'-geranyloxyferulic acid may be mediated in part by activating this PPAR isoform. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153754      PMCID: PMC2855212          DOI: 10.1016/j.lfs.2010.02.008

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  32 in total

1.  Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.

Authors:  S Kippenberger; S M Loitsch; M Grundmann-Kollmann; S Simon; T A Dang; K Hardt-Weinelt; R Kaufmann; A Bernd
Journal:  J Invest Dermatol       Date:  2001-12       Impact factor: 8.551

Review 2.  Peroxisome-proliferator-activated receptors and cancers: complex stories.

Authors:  Liliane Michalik; Béatrice Desvergne; Walter Wahli
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

Review 3.  PPARs and the complex journey to obesity.

Authors:  Ronald M Evans; Grant D Barish; Yong-Xu Wang
Journal:  Nat Med       Date:  2004-04       Impact factor: 53.440

4.  Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).

Authors:  J M Peters; S S Lee; W Li; J M Ward; O Gavrilova; C Everett; M L Reitman; L D Hudson; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

5.  Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

Authors:  B M Forman; J Chen; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.

Authors:  Moses T Bility; Jerry T Thompson; Richard H McKee; Raymond M David; John H Butala; John P Vanden Heuvel; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2004-08-13       Impact factor: 4.849

Review 7.  Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.

Authors:  Chih-Hao Lee; Peter Olson; Ronald M Evans
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

8.  Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

Authors:  Fred S Harman; Christopher J Nicol; Holly E Marin; Jerrold M Ward; Frank J Gonzalez; Jeffrey M Peters
Journal:  Nat Med       Date:  2004-03-28       Impact factor: 53.440

9.  Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis.

Authors:  Dae J Kim; Taro E Akiyama; Fred S Harman; Amanda M Burns; Weiwei Shan; Jerrold M Ward; Mary J Kennett; Frank J Gonzalez; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2004-03-19       Impact factor: 5.157

10.  Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing.

Authors:  Han Chung Chong; Ming Jie Tan; Virginie Philippe; Siew Hwey Tan; Chek Kun Tan; Chee Wai Ku; Yan Yih Goh; Walter Wahli; Liliane Michalik; Nguan Soon Tan
Journal:  J Cell Biol       Date:  2009-03-23       Impact factor: 10.539

View more
  3 in total

1.  Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.

Authors:  Michael G Borland; Prasad Krishnan; Christina Lee; Prajakta P Albrecht; Weiwei Shan; Moses T Bility; Craig B Marcus; Jyh M Lin; Shantu Amin; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2014-03-17       Impact factor: 4.944

Review 2.  Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury.

Authors:  Peng-fei WU; Zui ZHANG; Fang WANG; Jian-guo CHEN
Journal:  Acta Pharmacol Sin       Date:  2010-12       Impact factor: 6.150

Review 3.  Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.

Authors:  Chen Dong; Hui Zhou; Chong Shen; Lu-Gang Yu; Yi Ding; Yong-Hong Zhang; Zhi-Rong Guo
Journal:  World J Diabetes       Date:  2015-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.